EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 28-Apr-2025 22:08 ET (29-Apr-2025 02:08 GMT/UTC)

Vaccine shows promise against aggressive breast cancer

WashU Medicine
Peer-Reviewed Publication

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine — known as a neoantigen DNA vaccine — for breast cancer patients.

Journal: Genome Medicine
Funder: NIH/National Institutes of Health

Treatment advances, predictive biomarkers stand to improve bladder cancer care

University of North Carolina Health Care
Peer-Reviewed Publication

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk localized, muscle-invasive disease, according to an editorial published in the New England Journal of Medicine. Matthew Milowsky, MD, FASCO, a bladder cancer expert at UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center, says the promise of incorporating new treatments and predictive biomarkers to select the right patient for the right treatment every time offers a bright future for bladder cancer patients.

Journal: New England Journal of Medicine

This nifty AI tool helps neurosurgeons find sneaky cancer cells

University of California - San Francisco
Peer-Reviewed Publication

An AI-based diagnostic system reveals cancerous tissue that may not otherwise be visible during brain tumor surgery. This enables neurosurgeons to remove it while the patient is still under anesthesia – or treat it afterwards with targeted therapies.

Journal: Nature

Sylvester Tip Sheet: Hematology researchers present posters at the 66th ASH Annual Meeting & Exposition in San Diego

University of Miami Miller School of Medicine
Meeting Announcement

Hematology researchers from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami are authors or co-authors on more than 70 posters to be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10. Links to each abstract are included in this tip sheet.

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

University of Toronto - Leslie Dan Faculty of Pharmacy
Peer-Reviewed Publication

Regular, self-reported symptom screening was associated with reduced symptom burden when compared with usual care for pediatric patients with cancer, according to new research led by scientists at the University of Toronto and The Hospital for Sick Children (SickKids).

Journal: JAMA

UT Health San Antonio Multispecialty and Research Hospital dedication ushers in ‘a place of firsts’

University of Texas Health Science Center at San Antonio
Business Announcement

The University of Texas Health Science Center at San Antonio dedicated its new $472 million Multispecialty and Research Hospital, the only facility of its kind in South Texas where patients will have access to top specialists and pioneering therapies, especially in cancer treatment.

Sylvester Cancer researchers share findings in oral presentations at the ASH 2024 Annual Meeting & Exposition

University of Miami Miller School of Medicine
Meeting Announcement

Research findings from Sylvester Comprehensive Cancer Center and the Miller School of Medicine at the University of Miami will be presented at the Annual Meeting & Exposition of the American Society of Hematology in San Diego, Dec. 7-10. Links to oral presentations are included in this tip sheet.

“We need everyone”: New award recognizes the importance of scientific community

University of Utah Health
Grant and Award Announcement

In the lab of Minna Roh-Johnson, PhD, great science and great mentorship are inextricable. Now, up to $250,000 in federal funding from the National Cancer Institute has made that philosophy concrete via an Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship.

MRI-guided radiation therapy reduces long-term side effects for patients with prostate cancer

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer significantly reduced long-term side effects and improved quality of life, particularly in bowel and sexual health, compared to conventional CT-guided treatment.

Journal: European Urology

Cell therapy fights lethal childhood brain cancer in Stanford Medicine trial

Stanford Medicine
Peer-Reviewed Publication

CAR-T cells show promise against pediatric diffuse midline gliomas, brain and spinal cord tumors that are among the deadliest cancers, a Stanford Medicine trial found.

Journal: Nature